Skip to content
CholesterolResearch
← All people

Ivor Cummins

Biochemical/chemical engineer (not a physician); known as "The Fat Emperor"

An engineer who argues the cholesterol framework is wrong and that insulin resistance from high-carbohydrate, ultra-processed diets is the root cause of cardiovascular disease. His most useful contribution is championing the coronary artery calcium (CAC) score as a direct measure of disease, over cholesterol panels.

Position (a lossy summary - the nuance is below)

LDL: benign to causal

-0.85 (strongly toward "LDL benign")

LDL benignLDL causal

Argues LDL-C predicts actual coronary calcification poorly, that high LDL with high HDL and low triglycerides carries no increased risk, and that insulin-resistance markers (TG/HDL, fasting insulin, GGT) are the real signals - a strong rejection of LDL as a useful risk metric.

Statins: anti to pro

-0.50 (toward "Anti-statin")

Anti-statinPro-statin

Skeptical of statins for primary prevention but his emphasis is less on statins per se and more on measuring actual disease (CAC) and treating insulin resistance through diet and lifestyle.

A radical skeptic by training an engineer. His advocacy for CAC scoring as a direct disease measurement is genuinely valuable; his wholesale dismissal of LDL goes further than most skeptical physicians and his literature reading is self-taught.

Key arguments

  • The coronary artery calcium (CAC) score directly measures disease and beats cholesterol panels for prediction.
  • High LDL with high HDL and low triglycerides does not carry increased risk.
  • Insulin resistance (TG/HDL, fasting insulin, visceral fat) is the real driver.

Positions on specific claims

Conflicts of interest

Book sales ("Eat Rich, Live Long"), the "Fat Emperor" media/podcast brand, and speaking - a public identity built around the metabolic/skeptic position.

Fair criticisms

  • An engineer, not a physician or biomedical scientist; his literature interpretation is self-taught.
  • Frequently accused of confirmation bias.
  • His dismissal of LDL discounts the Mendelian-randomization and trial evidence.

Sources